• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗非骨骼疾病的药物的不良骨骼效应。

Adverse bone effects of medications used to treat non-skeletal disorders.

机构信息

Mercy Health Osteoporosis and Bone Health Services, 4760 E. Galbraith Rd., Suite 212, Cincinnati, OH, 45236, USA.

出版信息

Osteoporos Int. 2017 Oct;28(10):2741-2746. doi: 10.1007/s00198-017-4171-4. Epub 2017 Jul 27.

DOI:10.1007/s00198-017-4171-4
PMID:28752332
Abstract

There is a growing list of medications used to treat non-skeletal disorders that cause bone loss and/or increase fracture risk. This review discusses glucocorticoids, drugs that reduce sex steroids, antidiabetic agents, acid-reducing drugs, selective serotonin reuptake inhibitors, and heparin. A number of drugs are known to cause bone loss, increase fracture risk, or both. These drugs should be used in the lowest dose necessary to achieve the desired benefit and for the shortest time necessary, but in many cases, long-term treatment is required. Effective countermeasures are available for some.

摘要

用于治疗非骨骼疾病的药物越来越多,这些疾病会导致骨质流失和/或增加骨折风险。本综述讨论了糖皮质激素、降低性激素的药物、抗糖尿病药物、胃酸抑制药物、选择性 5-羟色胺再摄取抑制剂和肝素。许多药物已知会导致骨质流失、增加骨折风险或两者兼有。这些药物应在达到预期疗效所需的最低剂量和最短时间内使用,但在许多情况下,需要长期治疗。一些药物已经有了有效的对策。

相似文献

1
Adverse bone effects of medications used to treat non-skeletal disorders.用于治疗非骨骼疾病的药物的不良骨骼效应。
Osteoporos Int. 2017 Oct;28(10):2741-2746. doi: 10.1007/s00198-017-4171-4. Epub 2017 Jul 27.
2
[Fracture risk associated with drugs other than glucocorticoids].[除糖皮质激素外其他药物相关的骨折风险]
Clin Calcium. 2014 Mar;24(3):357-65.
3
Update on medications with adverse skeletal effects.药物相关骨骼不良事件的最新进展。
Mayo Clin Proc. 2011 Apr;86(4):338-43; quiz 343. doi: 10.4065/mcp.2010.0636. Epub 2011 Mar 9.
4
Drug-induced bone loss: a major safety concern in Europe.药物性骨丢失:欧洲的一大安全隐患。
Expert Opin Drug Saf. 2018 Oct;17(10):1005-1014. doi: 10.1080/14740338.2018.1524868. Epub 2018 Sep 23.
5
Glucocorticoid-induced Osteoporosis.糖皮质激素性骨质疏松症
Rheum Dis Clin North Am. 2016 Feb;42(1):177-89, x. doi: 10.1016/j.rdc.2015.08.005. Epub 2015 Oct 24.
6
[Antidiabetic drugs and their effect on bone].[抗糖尿病药物及其对骨骼的影响]
Vnitr Lek. 2017 Fall;63(9):609-616.
7
[Assessment of the treatment of glucocorticoid-induced osteoporosis].[糖皮质激素性骨质疏松症治疗的评估]
Clin Calcium. 2013 Mar;23(3):401-8.
8
Management of glucocorticoid-induced osteoporosis.糖皮质激素性骨质疏松症的管理。
Aging Clin Exp Res. 2021 Apr;33(4):793-804. doi: 10.1007/s40520-021-01823-0. Epub 2021 Mar 22.
9
[Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs].[继发性骨质疏松症或骨折中骨质流失的继发性因素。药物引起的代谢性骨病和骨折]
Clin Calcium. 2013 Sep;23(9):1307-12.
10
Glucocorticoid-Induced Bone Loss: Dietary Supplementation Recommendations to Reduce the Risk for Osteoporosis and Osteoporotic Fractures.糖皮质激素性骨丢失:降低骨质疏松症和骨质疏松性骨折风险的膳食补充建议。
Cutis. 2022 Oct;110(4):201-206. doi: 10.12788/cutis.0627.

引用本文的文献

1
Longitudinal changes of the femoral bone mineral density from first to third trimester of pregnancy: bone health assessment by means of non-ionizing REMS technology.妊娠第一至第三孕期股骨骨密度的纵向变化:非电离 REMs 技术的骨骼健康评估。
Aging Clin Exp Res. 2024 Feb 9;36(1):31. doi: 10.1007/s40520-023-02677-4.
2
The combined use of anti-peptic agents is associated with an increased risk of osteoporotic fracture: a nationwide case-control study.抑酸剂联合使用与骨质疏松性骨折风险增加相关:一项全国性病例对照研究。
Korean J Intern Med. 2024 Mar;39(2):228-237. doi: 10.3904/kjim.2023.326. Epub 2024 Feb 7.
3
The impact of medication on osseointegration and implant anchorage in bone determined using removal torque-A review.

本文引用的文献

1
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.2017 年美国风湿病学会糖皮质激素诱导性骨质疏松症预防和治疗指南。
Arthritis Rheumatol. 2017 Aug;69(8):1521-1537. doi: 10.1002/art.40137. Epub 2017 Jun 6.
2
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.Elagolix,一种口服 GnRH 拮抗剂,治疗子宫内膜异位症相关疼痛。
N Engl J Med. 2017 Jul 6;377(1):28-40. doi: 10.1056/NEJMoa1700089. Epub 2017 May 19.
3
Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany-A retrospective analysis of real-world data.
使用去除扭矩测定药物对骨内种植体骨结合和种植体固位的影响——综述
Heliyon. 2022 Oct 3;8(10):e10844. doi: 10.1016/j.heliyon.2022.e10844. eCollection 2022 Oct.
4
Selective serotonin reuptake inhibitors (SSRI) affect murine bone lineage cells.选择性 5-羟色胺再摄取抑制剂(SSRIs)影响小鼠骨系细胞。
Life Sci. 2020 Aug 15;255:117827. doi: 10.1016/j.lfs.2020.117827. Epub 2020 May 22.
5
Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management.肝素诱导的血小板减少症:病理生理学、诊断与管理
Cureus. 2020 Mar 24;12(3):e7385. doi: 10.7759/cureus.7385.
6
Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.抗凝治疗与房颤患者骨折风险的相关性。
JAMA Intern Med. 2020 Feb 1;180(2):245-253. doi: 10.1001/jamainternmed.2019.5679.
7
Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature.长期使用吸入性糖皮质激素治疗稳定期慢性阻塞性肺疾病患者与骨折风险:文献回顾性叙述。
Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1085-1097. doi: 10.2147/COPD.S190215. eCollection 2019.
8
Higher dose but not low dose proton pump inhibitors are associated with increased risk of subsequent hip fractures after first hip fracture: A nationwide observational cohort study.高剂量而非低剂量质子泵抑制剂与首次髋部骨折后发生后续髋部骨折的风险增加相关:一项全国性观察性队列研究。
Bone Rep. 2019 Apr 1;10:100204. doi: 10.1016/j.bonr.2019.100204. eCollection 2019 Jun.
使用二肽基肽酶-4 抑制剂与德国 2 型糖尿病患者骨折风险:真实世界数据的回顾性分析。
Osteoporos Int. 2017 Aug;28(8):2421-2428. doi: 10.1007/s00198-017-4051-y. Epub 2017 Apr 29.
4
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG.激素敏感性乳腺癌绝经后女性芳香化酶抑制剂相关骨丢失(AIBL)的管理:国际骨质疏松基金会(IOF)、中国抗癌协会乳腺癌专业委员会(CABS)、欧洲钙化组织协会(ECTS)、国际内分泌学会(IEG)、欧洲癌症研究与治疗组织乳腺癌协作组(ESCEO IMS)和国际老年肿瘤学会(SIOG)联合立场声明
J Bone Oncol. 2017 Mar 23;7:1-12. doi: 10.1016/j.jbo.2017.03.001. eCollection 2017 Jun.
5
Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation.达比加群与华法林在非瓣膜性心房颤动患者中与骨质疏松性骨折风险的相关性。
JAMA. 2017 Mar 21;317(11):1151-1158. doi: 10.1001/jama.2017.1363.
6
Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.抗精神病药的使用增加了骨折风险:系统评价和荟萃分析。
Osteoporos Int. 2017 Apr;28(4):1167-1178. doi: 10.1007/s00198-016-3881-3. Epub 2017 Jan 12.
7
Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.一项全国性研究中质子泵抑制剂的使用与髋部骨折后的死亡率
Osteoporos Int. 2017 May;28(5):1587-1595. doi: 10.1007/s00198-017-3910-x. Epub 2017 Jan 12.
8
Hyponatremia and fractures: should hyponatremia be further studied as a potential biochemical risk factor to be included in FRAX algorithms?低钠血症与骨折:低钠血症是否应作为一种潜在的生化风险因素进行进一步研究,以纳入FRAX算法中?
Osteoporos Int. 2017 May;28(5):1543-1548. doi: 10.1007/s00198-017-3907-5. Epub 2017 Jan 10.
9
Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.依度沙班与华法林用于有跌倒风险的房颤患者:ENGAGE AF-TIMI 48 分析。
J Am Coll Cardiol. 2016 Sep 13;68(11):1169-1178. doi: 10.1016/j.jacc.2016.06.034.
10
Diuretic Use and Risk of Vertebral Fracture in Women.女性利尿剂的使用与椎体骨折风险
Am J Med. 2016 Dec;129(12):1299-1306. doi: 10.1016/j.amjmed.2016.07.013. Epub 2016 Aug 16.